» Articles » PMID: 24733070

Preparation of Lung-targeting, Emodin-loaded Polylactic Acid Microspheres and Their Properties

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2014 Apr 16
PMID 24733070
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Emodin (1,3,8-trihydroxy-6-methylanthraquinone) has been identified to have the potential to improve lung fibrosis and lung cancer. To avoid the liver and kidney toxicities and the fast metabolism of emodin, emodin-loaded polylactic acid microspheres (ED-PLA-MS) were prepared and their characteristics were studied. ED-PLA-MS were prepared by the organic phase dispersion-solvent diffusion method. By applying an orthogonal design, our results indicated that the optimal formulation was 12 mg/mL PLA, 0.5% gelatin, and an organic phase:glycerol ratio of 1:20. Using the optimal experimental conditions, the drug loading and encapsulation efficiencies were (19.0±1.8)% and (62.2±2.6)%, respectively. The average particle size was 9.7±0.7 μm. In vitro studies indicated that the ED-PLA-MS demonstrated a well-sustained release efficacy. The microspheres delivered emodin, primarily to the lungs of mice, upon intravenous injection. It was also detected by microscopy that partial lung inflammation was observed in lung tissues and no pathological changes were found in other tissues of the ED-PLA-MS-treated animals. These results suggested that ED-PLA-MS are of potential value in treating lung diseases in animals.

Citing Articles

Multifunctional Bioactivity Electrospinning Nanofibers Encapsulating Emodin Provide a Potential Postoperative Management Strategy for Skin Cancer.

Ye P, Yusufu R, Guan Z, Chen T, Li S, Feng Y Pharmaceutics. 2024; 16(9).

PMID: 39339169 PMC: 11435127. DOI: 10.3390/pharmaceutics16091131.


Differential Mobility Spectrometry-Tandem Mass Spectrometry with Multiple Ion Monitoring Coupled with in Source-Collision Induced Dissociation: A New Strategy for the Quantitative Analysis of Pharmaceutical Polymer Excipients in Rat Plasma.

Zhang Y, Zhang Z, Liu Y, Cai D, Gu J, Sun D Molecules. 2023; 28(12).

PMID: 37375337 PMC: 10302547. DOI: 10.3390/molecules28124782.


Anticancer Potential of Xanthohumol and Isoxanthohumol Loaded into SBA-15 Mesoporous Silica Particles against B16F10 Melanoma Cells.

Krajnovic T, Pantelic N, Wolf K, Eichhorn T, Maksimovic-Ivanic D, Mijatovic S Materials (Basel). 2022; 15(14).

PMID: 35888494 PMC: 9320346. DOI: 10.3390/ma15145028.


Electrospun Coaxial Fibers to Optimize the Release of Poorly Water-Soluble Drug.

Liu Y, Chen X, Liu Y, Gao Y, Liu P Polymers (Basel). 2022; 14(3).

PMID: 35160459 PMC: 8839822. DOI: 10.3390/polym14030469.


Is Emodin with Anticancer Effects Completely Innocent? Two Sides of the Coin.

Akkol E, Tatli I, Seker Karatoprak G, Agar O, Yucel C, Sobarzo-Sanchez E Cancers (Basel). 2021; 13(11).

PMID: 34073059 PMC: 8198870. DOI: 10.3390/cancers13112733.


References
1.
Wang J, Ma Y, Zhang P, Jin C, Sun Y, Xiao X . [Effect of processing on the chemical contents and hepatic and renal toxicity of rhubarb studied by canonical correlation analysis]. Yao Xue Xue Bao. 2010; 44(8):885-90. View

2.
Wei Y, Zhao L . Passive lung-targeted drug delivery systems via intravenous administration. Pharm Dev Technol. 2013; 19(2):129-36. DOI: 10.3109/10837450.2012.757782. View

3.
Wang H, Xu Y, Zhou X . Docetaxel-loaded chitosan microspheres as a lung targeted drug delivery system: in vitro and in vivo evaluation. Int J Mol Sci. 2014; 15(3):3519-32. PMC: 3975351. DOI: 10.3390/ijms15033519. View

4.
Costa P, Sousa Lobo J . Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001; 13(2):123-33. DOI: 10.1016/s0928-0987(01)00095-1. View

5.
Zhang W, Jiang X, Zhu C, Hu J . [Study on the rifampicin polylactic acid microspheres for lung targeting]. Yao Xue Xue Bao. 2002; 33(1):57-61. View